Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Dynavax Technologies Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DVAX
Nasdaq
8731
https://www.dynavax.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Dynavax Technologies Corp
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
- Apr 24th, 2024 8:05 pm
11 Best Low Price Pharma Stocks To Invest In
- Apr 21st, 2024 2:39 pm
Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68%
- Mar 25th, 2024 11:58 am
Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX)
- Mar 5th, 2024 4:53 am
11 Best Small Cap Pharma Stocks to Invest In
- Mar 5th, 2024 1:28 am
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference
- Feb 27th, 2024 11:54 pm
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 3:34 pm
Q4 2023 Dynavax Technologies Corp Earnings Call
- Feb 23rd, 2024 11:38 am
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 1:00 am
Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4
- Feb 22nd, 2024 10:15 pm
Dynavax Technologies Corp (DVAX) Reports Robust Revenue Growth and Market Leadership in 2023
- Feb 22nd, 2024 9:44 pm
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
- Feb 22nd, 2024 9:01 pm
Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024
- Feb 8th, 2024 9:15 pm
3 Stocks Set to Soar 68% to 200% Higher
- Jan 9th, 2024 3:58 am
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
- Jan 8th, 2024 2:00 pm
Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why
- Jan 5th, 2024 1:50 pm
Insider Sell: Dynavax Technologies Corp President & COO David Novack Sells 9,000 Shares
- Jan 5th, 2024 8:03 am
Collegium (COLL) Shares Rise on Financial Outlook for 2024
- Jan 4th, 2024 3:40 pm
Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO
- Jan 4th, 2024 2:46 pm
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 11:33 pm
Scroll